Hepion Pharmaceuticals, Inc. (CTRVP) Operating cash flow 2016–2025
Hepion Pharmaceuticals, Inc. (CTRVP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.3MFY2025 · since FY2016: -$19.2M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +82.0% |
| FY2024 | -$18.2M | +55.4% |
| FY2023 | -$40.9M | -17.0% |
| FY2022 | -$35.0M | -12.0% |
| FY2021 | -$31.2M | -93.2% |
| FY2020 | -$16.2M | -113.7% |
| FY2019 | -$7.6M | +51.6% |
| FY2018 | -$15.6M | — |
| FY2016 | -$19.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTRVP financial trends
CTRVP RevenueCTRVP Net incomeCTRVP Net marginCTRVP Gross profitCTRVP Gross marginCTRVP Operating incomeCTRVP Operating marginCTRVP Free cash flowCTRVP Capital expendituresCTRVP Return on equityCTRVP Stock buybacksCTRVP Dividends paidCTRVP Total assetsCTRVP Total liabilitiesCTRVP Shareholders’ equityCTRVP overview →